OptraLABS gets ICMR approval for COVID-19 recovery test kits Optra-Shield

"OptraLABS kits for Recovery Testing is the solution. These kits can be used at home or work. These kits are also particularly useful to test the effect of COVID-19 vaccine. We are not only manufacturing these in India but also made sure that our kits cost-effective. We are making Optra-Shield available at Rs 350 in India," he further said.

"There are additional ways where this test kit could be very helpful, especially after the anticipated mass-vaccination programs against SARS-CoV2. This kit can be utilized by the governmental health agencies to monitor the administration and efficacy of their immunization program. This could be monitored by user-submitted data after the vaccine recipient uses the COVID-Shield test at home post-vaccination after a prescribed time. Recalling patients after vaccination to conduct diagnostic serological tests for antibody development may be a difficult task, especially in countries like India and other South Asian countries where the compliance for return visits could be low. Thus, a self-administrable kit by OptraLABS could fulfill that need in an affordable, accessible, and traceable way," said Dr. Achal Pashine, a well-known scientist and ex-Director at Bristol Myers Squibb, GSK, and Roche.

OptraLABS is the world's first-ever solution provider focused on providing a complete suite to defeat COVID-19. Through its continuous technological innovations, it aims at defeating the virus at every step.

OptraLABS is a wholly-owned subsidiary of Optra Group of companies. OptraSCAN, a digital pathology venture, OptraHEALTH a genetic testing venture, Devisha Films a National award winner entertainment company are some of its other group companies.